Breast Cancer Risk Reduction in Primary Care Clinics: A Bilingual Intervention for Women and Physicians
Investigator: Celia P. Kaplan, DrPH
Sponsor: Susan G. Komen Breast Cancer Foundation
Location(s): United States
a randomized controlled trial to evaluate the effectiveness of a tablet computer-based breast cancer risk education intervention (BreastCare) to: a) facilitate discussion of breast cancer risk reduction practices, b) improve patient-clinician communication of breast cancer risk, and c) improve patient knowledge about her individual risk of developing breast cancer.
Specific hypotheses to be tested in future randomized controlled trials of the intervention are:
1. Patient acceptability: Women participating in the BreastCare intervention group will indicate high rates of satisfaction with the format and content of the intervention.
2. Impact: Women participating in the BreastCare intervention group will report greater participation in patient-physician discussion of breast cancer risk, have increased knowledge and understanding of risk reduction options, and have more up to-date mammography screening as compared to those in the comparison condition.